BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29133945)

  • 1. MicroRNA-7-5p mediates the signaling of hepatocyte growth factor to suppress oncogenes in the MCF-10A mammary epithelial cell.
    Jeong D; Ham J; Park S; Lee S; Lee H; Kang HS; Kim SJ
    Sci Rep; 2017 Nov; 7(1):15425. PubMed ID: 29133945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of miR-362-5p and miR-454-3p expression elicits diverse responses in breast cancer cell lines.
    Aarthy R; Rao AKDM; Patel K; Sridevi V; Rajkumar T; Gowda H; Mani S
    Mol Biol Rep; 2022 Jan; 49(1):821-826. PubMed ID: 34727290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma.
    Susuki D; Kimura S; Naganuma S; Tsuchiyama K; Tanaka T; Kitamura N; Fujieda S; Itoh H
    Cancer Sci; 2011 Dec; 102(12):2164-71. PubMed ID: 21899661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells.
    Liu C; Guo H; Cheng X; Shao M; Wu C; Wang S; Li H; Wei L; Gao Y; Tan W; Cheng S; Wu T; Yu D; Lin D
    Oncotarget; 2015 Oct; 6(30):29428-39. PubMed ID: 26338969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met.
    Gao Y; Zeng F; Wu JY; Li HY; Fan JJ; Mai L; Zhang J; Ma DM; Li Y; Song FZ
    Tumour Biol; 2015 Apr; 36(4):2875-83. PubMed ID: 25492484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
    Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
    Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
    Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
    Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR; Tortora G
    Int J Cancer; 1993 Feb; 53(3):438-43. PubMed ID: 8094073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7.
    Zhu B; Wei XX; Wang TB; Zhou YC; Liu AM; Zhang GW
    Arch Virol; 2015 Aug; 160(8):2043-50. PubMed ID: 26071245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-145 inhibits breast cancer cell growth through RTKN.
    Wang S; Bian C; Yang Z; Bo Y; Li J; Zeng L; Zhou H; Zhao RC
    Int J Oncol; 2009 May; 34(5):1461-6. PubMed ID: 19360360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis.
    Lo PK; Zhang Y; Wolfson B; Gernapudi R; Yao Y; Duru N; Zhou Q
    Oncotarget; 2016 Oct; 7(40):65067-65089. PubMed ID: 27556296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
    Si Y; Zhang H; Ning T; Bai M; Wang Y; Yang H; Wang X; Li J; Ying G; Ba Y
    Cell Physiol Biochem; 2017; 42(4):1670-1683. PubMed ID: 28738343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide small RNA sequencing and gene expression analysis reveals a microRNA profile of cancer susceptibility in ATM-deficient human mammary epithelial cells.
    Hesse JE; Liu L; Innes CL; Cui Y; Palii SS; Paules RS
    PLoS One; 2013; 8(5):e64779. PubMed ID: 23741392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
    Teo CR; Casey PJ; Rasheed SA
    Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.